Details for New Drug Application (NDA): 061455
✉ Email this page to a colleague
NDA 061455 describes DICLOXACILLIN SODIUM, which is a drug marketed by Aurobindo Pharma, Chartwell Rx, Teva, and Apothecon, and is included in four NDAs. It is available from eight suppliers. Additional details are available on the DICLOXACILLIN SODIUM profile page.
The generic ingredient in DICLOXACILLIN SODIUM is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
The generic ingredient in DICLOXACILLIN SODIUM is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
Summary for 061455
| Tradename: | DICLOXACILLIN SODIUM |
| Applicant: | Apothecon |
| Ingredient: | dicloxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061455
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 62.5MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
